Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J.-Timothy Qiu"'
Autor:
Dito Anurogo, Chia-Yuan Chen, Chu-Chi Lin, Jeanne Adiwinata Pawitan, Daniel W. Qiu, J. Timothy Qiu
Publikováno v:
Journal of Immunotoxicology, Vol 21, Iss 1 (2024)
Infections caused by the influenza virus lead to both epidemic and pandemic outbreaks in humans and animals. Owing to their rapid production, safety, and stability, DNA vaccines represent a promising avenue for eliciting immunity and thwarting viral
Externí odkaz:
https://doaj.org/article/d02dd6f30363438db5dbe6495b524511
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 60, Iss 4, Pp 700-705 (2021)
Objective: To generate immunity against human papillomavirus (HPV), the use of a recombinant DNA vaccine to carry an appropriate target gene is a promising and cost-effective approach. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a po
Externí odkaz:
https://doaj.org/article/b97ec50d9ba94e8c9e5ffce79a512318
Autor:
I.-Ning Chen, I.-Te Wang, Hsueh-Yu Mu, J.-Timothy Qiu, Wei-Min Liu, Ching-Wen Chang, Yen-Hsieh Chiu
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2117
Objectives: To compare the survival outcomes between minimally invasive surgery (MIS) and laparotomy radical hysterectomy in patients with early-stage cervical cancer. Methods: We conducted a retrospective study involving women who received a radical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59bf3834802e4d490018896b68654163
Publikováno v:
Taiwanese journal of obstetricsgynecology. 60(4)
To generate immunity against human papillomavirus (HPV), the use of a recombinant DNA vaccine to carry an appropriate target gene is a promising and cost-effective approach. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2d130871f4b95295f843dfd2432b989
https://pubmed.ncbi.nlm.nih.gov/34247810
https://pubmed.ncbi.nlm.nih.gov/34247810
Autor:
Hao Lin, Ren-Chin Wu, Chyong-Huey Lai, Kuan Gen Huang, Huei Jean Huang, Wei-Yang Chang, Ting-Chang Chang, Min Yu Chen, Hung Hsueh Chou, Angel Chao, Wei-Chun Chen, J. Timothy Qiu, Lan-Yan Yang
Publikováno v:
Journal of Clinical Oncology. 39:5540-5540
5540 Background: The objective of this study is to evaluate the safety and efficacy of adding bevacizumab to dose-dense adjuvant chemotherapy with bevacizumab maintenance after neoadjuvant chemotherapy (NAC) and interval debulking surgery (IDS) for s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::258c4de0d7efe972bf095d2cd06de6c6
https://doi.org/10.1200/jco.2021.39.15_suppl.5540
https://doi.org/10.1200/jco.2021.39.15_suppl.5540